2/3 of the way through the quarter so no I don't think so.
Based upon the AGM presentation I think a lot of the growth (from the US) is dependent upon ongoing trials which won't complete until Q3 & as such will turn into sales in the mid to later half of H2.
Europe is in lockdown & so demand will continue to be at a lower level there in Q2 IMO.
All IMO, very difficult to predict ZNO revenue.
H1 FY21 could be as low as $20m or as high as $30m, the above is just where I think it will end up.
2/3 of the way through the quarter so no I don't think so.Based...
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.889M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 180167 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 337693 | 1 |
View Market Depth
| Last trade - 08.49am 16/08/2024 (20 minute delay) ? |
| ZNO (ASX) Chart |
Day chart unavailable